SaferWorldbyDesign Webinar: Current skin safety assessment advances and challenges

Progress in the use of new approach methods (NAMSs) in solving problems 

Tuesday 7 April 2020

10.00-11:00 East Coast, 16-17:00 CET - (7 am California, 10 am New York, 15.00 London, 16.00 Zurich, 20.30 New Delhi, 24.00 Tokyo)

Signup here

This virtual meeting will include a perspective facilitated by Barry Hardy and a guest panel on Skin Safety Assessment on the following topics, followed by a discussion session. 

  • Barry Hardy, CEO, Edelweiss Connect - Insights from our stakeholder industry perspective 
  • Christophe Chesne, CEO, Wepredic - Advances in formulation testing and assessment 
  • Tomaž Mohorič, Computational Scientist, Edelweiss Connect - Use of machine learning methods in assessment  
  • Michael Dourson & Bernard Gadagbui, TERA - Risk assessment perspectives 

Skin safety is one of the most important goals of the consumer products industry. The cosmetics industry is a lead developer and end-user of new approach methods (NAMs) to replace previously used animal experiments. New human clinical evidence is only available when there is strong justification. The first step in product decision making should always be to consider using all currently available evidence from data and models including read-across. Additionally, new data from tiered testing approaches including NAMs applied to formulations can provide values for safety assessment with increased confidence and reduced uncertainties.

Latest Tweets

Edelweiss Connect (Yesterday)
The goal of this webinar and discussion is to provide insight into the combined use of in silico and in vitro evide… https://t.co/W3hE1Cm95K
Edelweiss Connect (Yesterday)
#SaferWorldbyDesign presents: Skin safety assessment according to OECD guidelines Join us on December 17 for a we… https://t.co/oGymiPDVp0
Edelweiss Connect (2 days ago)
JRC Data Visualization: Extrapolating from acute to chronic toxicity in vitro An important question that was addre… https://t.co/B5Ius3qtDk
Edelweiss Connect (2 days ago)
#SaferWorldbyDesign webinar: In Silico solutions for drug discovery Presented by @Maieutix1 #insilico… https://t.co/Ya5J0ySQ0Q
Edelweiss Connect (2 weeks ago)
See why @wepredic @Biopredic_Intl #HepaRG™ cell model is the best for NAFLD investigations #SaferWorldbyDesign… https://t.co/pzgJbUhY7d

Get in touch

  • Address: Edelweiss Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland

USA office

  • Address: Edelweiss Connect Inc
    Research Triangle Park NC
    800 Park Offices Dr
    Durham, NC 27709
    USA